Actions
Pages
Subscribe for newsletter
Stories
Nanomedicine enables targeted drug delivery at the molecular and cellular levels. This precision allows for the delivery of therapeutic agents directly to the affected cells or tissues and can minimize side effects. Taiwan Liposome Company (TLC) is a clinical-stage biotech firm dedicated to developing and commercializing nanomedicines. Their focus is a proprietary lipid-assembled drug delivery platform using approved active pharmaceutical ingredients (APIs).
The nanomedicine industry is on a growth trajectory, projected to reach $358 billion by 2032.
TLC leverages the streamlined 505(b)(2) regulatory pathway in the United States due to its use of already approved APIs. This simplifies the approval process for their product candidates. TLC's collaborations with Endo and 3SBio for commercialization and regulatory approvals in new markets will expand its global footprint.
Expect TLC to leverage its proprietary technologies and partnerships to launch innovative products in key markets. The focus will be on expanding its customer base and navigating regulatory landscapes to deliver advanced therapies to more patients worldwide.
Story
Norway breaks ground as the first country to greenlight commercial deep-sea mining, unlocking Arctic riches for economic diversification.
The Arctic Ocean, abundant in rare earth elements and other minerals, is crucial for technologies central to the green revolution, like electric vehicles and renewable energy systems. Accessing these resources could diminish reliance on land-based mining, which is increasingly costly and environmentally damaging.
The future of deep-sea mining in the Arctic Ocean hinges on technological advancements and regulatory frameworks. As trials and projects progress, the industry's ability to minimize environmental impacts while maximizing resource extraction will be under scrutiny.
Story
Playbux, a Web3 entertainment platform that offers shop-to-earn experiences, plans to raise $150,000 through a fair community offering (FCO) instead of the usual initial coin offering (ICO). The FCO, facilitated by crypto investing platform Raiser, involves ranking users based on on-chain activity, referrals, educational quizzes, and profile following. Users with higher rankings get the opportunity to invest in the project's token before it is listed on centralized exchanges.
FCO is introduced as an alternative to ICOs, which were common but became associated with fraud during the crypto boom of 2017-2018. ICOs lacked reporting requirements and accounting standards, leading to fraudulent activities. The decline of ICOs has paved the way for new fundraising mechanisms, such as airdrops. FCO aims to address the shortcomings of ICOs by aligning with more rigorous listing requirements while providing pre-listing token access to the community.
“Our goal is to effectively support both the community and centralized exchanges, who show belief in the potential success of new projects through initial listings. Our unique platform rewards active community members and so assists exchanges in their strategic decisions,” said Raiser’s Co-founder and CEO Kori Leon.
Playbux will conduct its public FCO for the PBUX token in late January. The platform was part of Binance Labs' incubation program and was added to Visa's Asia Pacific 2023 accelerator program. Its success could prompt similar offerings by other Web3 firms, shifting crypto investments to more community-centered, equitable approaches.
Story
Innovators
Scroll
Open
Close